Larotrectinib price in China

Larotrectinib (Larotrectinib) has been launched in China, but it has not yet been included in medical insurance. Since it has not been launched in China for a long time, it may be difficult to purchase in China. Please consult the local hospital pharmacy for details. There are original drugs and generic drugs of larotrectinib abroad. The original drugs include German version, American version, European version and Hong Kong version. The price is basically around 20,000 yuan. Generic drugs include Lao and Bangladeshi versions, with prices ranging from two to three thousand. The ingredients of original drugs and generic drugs are basically the same.

Exact prices and availability of drugs often vary widely by country, region, health insurance and hospital. In addition, the price of drugs may change over time, depending on factors such as market supply and demand, competition and government policies. Therefore, I cannot provide specific price information about larotrectinib in China.

Larotinib is a targeted therapy specifically designed to treatTRK gene fusion-positive tumors. If you or your doctor are interested in larotrectinib, it is recommended that you contact a medical professional or hospital in your country to obtain the latest information on the price and availability of this drug. You can also check with your health insurance company to determine whether there is relevant health insurance coverage.

In addition, some countries may have drug price control policies or medical assistance programs, which may have an impact on patient payments. Therefore, it is also important to understand relevant policies and resources.

In summary, the best way to learn about the price and availability of larotrectinib in your country is to contact your local health care provider and pharmaceutical organization, who can provide specific information and help you make an appropriate decision.